Akebia Therapeutics ( NASDAQ:AKBA – Get Free Report ) released its quarterly earnings results on Friday. The biopharmaceutical company reported ($0.06) EPS for the quarter, missing analysts' consensus estimates of ($0.03) by ($0.03), MarketWatch Earnings reports. Akebia Therapeutics had a negative net margin of 20.79% and a negative return on equity of 235.17%. During the same quarter in the previous year, the business earned $0.23 EPS. Akebia Therapeutics Price Performance AKBA opened at $1.

https://www.dailypolitical.com/2023/08/26/akebia-therapeutics-nasdaqakba-releases-earnings-results-misses-estimates-by-0-03-eps.html

#dailypolitical